Terms: = Prostate cancer AND MAX, MGC36767, 4149, ENSG00000125952, MGC18164, MGC10775, P61244, MGC11225, orf1, MGC34679 AND Diagnosis
73 results:
1. Key learnings from concordant systematic biopsies in prostate-specific membrane antigen positron emission tomography/computed tomography-guided prostate biopsies: Enhancing targeting accuracy.
Büttner T; Gärtner F; Essler M; Weiten R; Kristiansen G; Ellinger J; Ritter M; Krausewitz P
Prostate; 2024 Jun; 84(8):772-779. PubMed ID: 38504659
[TBL] [Abstract] [Full Text] [Related]
2. Intense 18 F-PSMA-1007 Uptake of Splenic Hemangioma.
Jia G; Dong A; Cheng C; Zuo C
Clin Nucl Med; 2024 Feb; 49(2):e90-e92. PubMed ID: 38048527
[TBL] [Abstract] [Full Text] [Related]
3. Intra-individual comparison of prostate-specific membrane antigen positron emission tomography/computed tomography versus bone scan in detecting skeletal metastasis at prostate cancer diagnosis.
Shanmugasundaram R; Saad J; Heyworth A; Wong V; Pelecanos A; Arianayagam M; Canagasingham B; Ferguson R; Goolam AS; Khadra M; Kam J; Ko R; McCombie S; Varol C; Winter M; Mansberg R; Nguyen D; Bui C; Loh H; Le K; Roberts MJ
BJU Int; 2024 Feb; 133 Suppl 3():25-32. PubMed ID: 37943964
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic Performance of PSMA-Based 18 F-DCFPyL PET/CT in prostate cancer Patients After Definitive Treatment With PSA Level ≤0.2 ng/mL.
Lu Y; Wilson ZJ; Xu G; Xu Z; Pan T; Wei P
Clin Nucl Med; 2023 Dec; 48(12):1021-1027. PubMed ID: 37801580
[TBL] [Abstract] [Full Text] [Related]
5. Comparison of parametric imaging and SUV imaging with [
Chen R; Ng YL; Yang X; Zhu Y; Li L; Zhao H; Zhou Y; Huang G; Liu J
Eur J Nucl Med Mol Imaging; 2024 Jan; 51(2):568-580. PubMed ID: 37792025
[TBL] [Abstract] [Full Text] [Related]
6.
Ma XK; Liu TL; Ren YN; Ma XP; Yao Y; Hou XG; Ding J; Wang F; Huang HF; Zhu H; Yang Z
Acta Pharmacol Sin; 2024 Feb; 45(2):436-448. PubMed ID: 37749238
[TBL] [Abstract] [Full Text] [Related]
7. A prostate-Specific Membrane Antigen PET-Based Approach for Improved diagnosis of prostate cancer in Gleason Grade Group 1: A Multicenter Retrospective Study.
Zhang J; Kang F; Gao J; Jiao J; Quan Z; Ma S; Li Y; Guo S; Li Z; Jing Y; Zhang K; Yang F; Han D; Wen W; Zhang J; Ren J; Wang J; Guo H; Qin W
J Nucl Med; 2023 Nov; 64(11):1750-1757. PubMed ID: 37652543
[TBL] [Abstract] [Full Text] [Related]
8. Simultaneous thulium laser resection of the prostate and transperineal prostate biopsy in clinically diagnosed metastatic prostate cancer with bladder outlet obstruction.
Shi Y; Cao T; Xu J; Cui D; Wang X; Zhu Y; Ruan Y; Han B; Xia S; Chen Y; Guo W; Jing Y
Lasers Med Sci; 2023 Aug; 38(1):188. PubMed ID: 37596454
[TBL] [Abstract] [Full Text] [Related]
9. Head-to-Head Comparison of 68 Ga-P16-093 and 68 Ga-PSMA-617 PET/CT in Patients With Primary prostate cancer : A Pilot Study.
Wang G; Li L; Zang J; Hong H; Zhu L; Kung HF; Zhu Z
Clin Nucl Med; 2023 Apr; 48(4):289-295. PubMed ID: 36727866
[TBL] [Abstract] [Full Text] [Related]
10. Consecutive prostate-Specific Membrane Antigen (PSMA) and Antigen Receptor (AR) PET Imaging Shows Positive Correlation with AR and PSMA Protein Expression in Primary Hormone-Naïve prostate cancer.
Al Jalali V; Wasinger G; Rasul S; Grubmüller B; Wulkersdorfer B; Balber T; Mitterhauser M; Simon J; Hacker M; Shariat S; Egger G; Zeitlinger M
J Nucl Med; 2023 Jun; 64(6):863-868. PubMed ID: 36657982
[TBL] [Abstract] [Full Text] [Related]
11. Unspecific
Seifert R; Telli T; Opitz M; Barbato F; Berliner C; Nader M; Umutlu L; Stuschke M; Hadaschik B; Herrmann K; Fendler WP
J Nucl Med; 2023 May; 64(5):738-743. PubMed ID: 36460340
[No Abstract] [Full Text] [Related]
12. Cross-cultural differences in men on active surveillance' anxiety: a longitudinal comparison between Italian and Dutch patients from the prostate cancer Research International Active Surveillance study.
Dordoni P; Remmers S; Valdagni R; Bellardita L; De Luca L; Badenchini F; Marenghi C; Roobol MJ; Venderbos LDF
BMC Urol; 2022 Jul; 22(1):110. PubMed ID: 35850672
[TBL] [Abstract] [Full Text] [Related]
13. Bone Uptake in prostate cancer Patients: Diagnostic Performances of PSMA-RADS v1.0, Clinical, Biological, and 68 Ga-PSMA-11 PET Features to Predict Metastasis After Biochemical Recurrence.
Letang A; Crombé A; Rousseau C; Sargos P; Merlin C; Cantarel C; Cazeau AL
Clin Nucl Med; 2022 Aug; 47(8):e529-e539. PubMed ID: 35543633
[TBL] [Abstract] [Full Text] [Related]
14.
Moradi F; Duan H; Song H; Davidzon GA; Chung BI; Thong AEC; Loening AM; Ghanouni P; Sonn G; Iagaru A
J Nucl Med; 2022 Dec; 63(12):1822-1828. PubMed ID: 35512996
[TBL] [Abstract] [Full Text] [Related]
15. Decisional Conflict is Associated with Treatment Modality and not Disease Knowledge in South African Men with prostate cancer: Baseline Results from a Longitudinal Prospective Observational Study.
Irusen H; Burger H; Fernandez PW; Van der Merwe A; Esterhuizen T; du Plessis DE; Seedat S
Cancer Control; 2022; 29():10732748221082791. PubMed ID: 35442835
[TBL] [Abstract] [Full Text] [Related]
16. The PRIMARY Score: Using Intraprostatic
Emmett L; Papa N; Buteau J; Ho B; Liu V; Roberts M; Thompson J; Moon D; Sheehan-Dare G; Alghazo O; Agrawal S; Murphy D; Stricker P; Hope TA; Hofman MS
J Nucl Med; 2022 Nov; 63(11):1644-1650. PubMed ID: 35301240
[TBL] [Abstract] [Full Text] [Related]
17. Impact of COVID-19 on Radiation Oncology, an Austrian Experience.
Mangesius J; Arnold CR; Seppi T; Mangesius S; Brüggl M; Eichberger P; Ganswindt U
Curr Oncol; 2021 Nov; 28(6):4776-4785. PubMed ID: 34898552
[TBL] [Abstract] [Full Text] [Related]
18. Detection of Additional Primary Neoplasms on
Parihar AS; Schmidt LR; Dehdashti F; Wahl RL
J Nucl Med; 2022 May; 63(5):713-719. PubMed ID: 34413144
[TBL] [Abstract] [Full Text] [Related]
19. Prospective study of diagnostic accuracy in the detection of high-grade prostate cancer in biopsy-naïve patients with clinical suspicion of prostate cancer who underwent the Select MDx test.
Lendínez-Cano G; Ojeda-Claro AV; Gómez-Gómez E; Morales Jimenez P; Flores Martin J; Dominguez JF; Amores J; Cozar JM; Bachiller J; Juárez A; Linares R; Garcia Galisteo E; Alvarez Ossorio JL; Requena Tapia MJ; Moreno Jimenez J; Medina Lopez RA;
Prostate; 2021 Sep; 81(12):857-865. PubMed ID: 34184761
[TBL] [Abstract] [Full Text] [Related]
20. Mapping the Memorial Anxiety Scale for prostate cancer to the SF-6D.
Erim DO; Bennett AV; Gaynes BN; Basak RS; Usinger D; Chen RC
Qual Life Res; 2021 Oct; 30(10):2919-2928. PubMed ID: 33993437
[TBL] [Abstract] [Full Text] [Related]
[Next]
